glp 1 reducing inflammation Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss Central glucagon-like peptide 1 receptor

Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications

How tapering can help Tapering is the process of either gradually lowering your dose over the course of several weeks or stretching out your dose frequency, going from weekly injections to every other week, then every three weeks, and so on

Abstract Glucagon-like peptide-1 receptor (GLP-1R) agonists have garnered significant attention for their therapeutic potential in addressing the interconnected health challenges of diabetes, obesity, and cancer

What Medications May Be Covered

A patient arrives having heard about Wegovy or Mounjaro perhaps from a news article, perhaps from a friend who has lost significant weight, and the discussion centres almost entirely on efficacy and tolerability